» Articles » PMID: 34988021

Tumor Associated Macrophages: Origin, Recruitment, Phenotypic Diversity, and Targeting

Overview
Journal Front Oncol
Specialty Oncology
Date 2022 Jan 6
PMID 34988021
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

The tumor microenvironment (TME) is known to have a strong influence on tumorigenesis, with various components being involved in tumor suppression and tumor growth. A protumorigenic TME is characterized by an increased infiltration of tumor associated macrophages (TAMs), where their presence is strongly associated with tumor progression, therapy resistance, and poor survival rates. This association between the increased TAMs and poor therapeutic outcomes are stemming an increasing interest in investigating TAMs as a potential therapeutic target in cancer treatment. Prominent mechanisms in targeting TAMs include: blocking recruitment, stimulating repolarization, and depletion methods. For enhancing targeting specificity multiple nanomaterials are currently being explored for the precise delivery of chemotherapeutic cargo, including the conjugation with TAM-targeting peptides. In this paper, we provide a focused literature review of macrophage biology in relation to their role in tumorigenesis. First, we discuss the origin, recruitment mechanisms, and phenotypic diversity of TAMs based on recent investigations in the literature. Then the paper provides a detailed review on the current methods of targeting TAMs, including the use of nanomaterials as novel cancer therapeutics.

Citing Articles

Bone Marrow Origin of Mammary Phagocytic Intraductal Macrophages (Foam Cells).

Barsky S, Mcphail K, Wang J, Hoffman R, Ye Y Int J Mol Sci. 2025; 26(4).

PMID: 40004162 PMC: 11855042. DOI: 10.3390/ijms26041699.


Cell fusion as a driver of metastasis: re-evaluating an old hypothesis in the age of cancer heterogeneity.

Lopez-Collazo E, Hurtado-Navarro L Front Immunol. 2025; 16:1524781.

PMID: 39967663 PMC: 11832717. DOI: 10.3389/fimmu.2025.1524781.


The ubiquitin ligase Pellino1 targets STAT3 to regulate macrophage-mediated inflammation and tumor development.

Hwang S, Park J, Koo S, Lee S, Jo Y, Ryu D Nat Commun. 2025; 16(1):1256.

PMID: 39893188 PMC: 11787384. DOI: 10.1038/s41467-025-56440-6.


The Dual Role of Cellular Senescence in Macrophages: Unveiling the Hidden Driver of Age-Related Inflammation in Kidney Disease.

Wang Y, Li T, Wang F, Yao X, Bai Q, Su H Int J Biol Sci. 2025; 21(2):632-657.

PMID: 39781471 PMC: 11705649. DOI: 10.7150/ijbs.104404.


-polarized M2-like tumor-associated macrophages accelerate colorectal cancer development via IL-8 secretion.

Nguyen D, Kang M, Oh S, Park H, Kim S, Yu J Anim Cells Syst (Seoul). 2025; 29(1):24-34.

PMID: 39777026 PMC: 11703389. DOI: 10.1080/19768354.2024.2442401.


References
1.
Riabov V, Gudima A, Wang N, Mickley A, Orekhov A, Kzhyshkowska J . Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis. Front Physiol. 2014; 5:75. PMC: 3942647. DOI: 10.3389/fphys.2014.00075. View

2.
Zhou R, Zhou Y, Chen Z . Exploration of macrophage colony-stimulating factor as a new type of tumor marker. Biomed Rep. 2014; 1(6):845-849. PMC: 3917021. DOI: 10.3892/br.2013.170. View

3.
Asai A, Tsuchimoto Y, Ohama H, Fukunishi S, Tsuda Y, Kobayashi M . Host antitumor resistance improved by the macrophage polarization in a chimera model of patients with HCC. Oncoimmunology. 2017; 6(4):e1299301. PMC: 5414886. DOI: 10.1080/2162402X.2017.1299301. View

4.
Yang M, Li Z, Ren M, Li S, Zhang L, Zhang X . Stromal Infiltration of Tumor-Associated Macrophages Conferring Poor Prognosis of Patients with Basal-Like Breast Carcinoma. J Cancer. 2018; 9(13):2308-2316. PMC: 6036715. DOI: 10.7150/jca.25155. View

5.
Kowal J, Kornete M, Joyce J . Re-education of macrophages as a therapeutic strategy in cancer. Immunotherapy. 2019; 11(8):677-689. DOI: 10.2217/imt-2018-0156. View